Dynamic activation of rAAV transgene expression by a small molecule that recruits endogenous transcriptional machinery
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 46 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 46 samples: 12 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Dynamic activation of rAAV transgene expression by a small molecule that recruits endogenous transcriptional machineryNucleic acids research · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE272562_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1137350 and SRA study SRP520807. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 45 samples.
How we read this: 12 replicated groups read from 46 sample titles; they account for 45 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8404607 U2OS BRD4 no treatment Rep1 U2OS BRD4 no treatment
- GSM8404608 U2OS BRD4 no treatment Rep2 U2OS BRD4 no treatment
- GSM8404609 U2OS BRD4 no treatment Rep3 U2OS BRD4 no treatment
- GSM8404610 U2OS BRD4 no treatment Rep4 U2OS BRD4 no treatment
- GSM8404611 U2OS BRD4 C207 treatment Rep1 U2OS BRD4 C207 treatment
- GSM8404612 U2OS BRD4 C207 treatment Rep2 U2OS BRD4 C207 treatment
- GSM8404613 U2OS BRD4 C207 treatment Rep3 U2OS BRD4 C207 treatment
- GSM8404614 U2OS BRD4 C207 treatment Rep4 U2OS BRD4 C207 treatment
- GSM8404615 U2OS H3K9ac no treatment Rep1 U2OS H3K9ac no treatment
- GSM8404616 U2OS H3K9ac no treatment Rep2 U2OS H3K9ac no treatment
- GSM8404617 U2OS H3K9ac no treatment Rep3 U2OS H3K9ac no treatment
- GSM8404618 U2OS H3K9ac no treatment Rep4 U2OS H3K9ac no treatment
- GSM8404619 U2OS H3K9ac C207 treatment Rep1 U2OS H3K9ac C207 treatm…
- GSM8404620 U2OS H3K9ac C207 treatment Rep2 U2OS H3K9ac C207 treatm…
- GSM8404621 U2OS H3K9ac C207 treatment Rep3 U2OS H3K9ac C207 treatm…
- GSM8404622 U2OS H3K9ac C207 treatment Rep4 U2OS H3K9ac C207 treatm…
- GSM8404623 U2OS H3K27ac no treatment Rep1 U2OS H3K27ac no treatme…
- GSM8404624 U2OS H3K27ac no treatment Rep2 U2OS H3K27ac no treatme…
- GSM8404625 U2OS H3K27ac no treatment Rep3 U2OS H3K27ac no treatme…
- GSM8404626 U2OS H3K27ac no treatment Rep4 U2OS H3K27ac no treatme…
- GSM8404627 U2OS H3K27ac C207 treatment Rep1 U2OS H3K27ac C207 treat…
- GSM8404628 U2OS H3K27ac C207 treatment Rep2 U2OS H3K27ac C207 treat…
- GSM8404629 U2OS H3K27ac C207 treatment Rep3 U2OS H3K27ac C207 treat…
- GSM8404630 U2OS H3K27ac C207 treatment Rep4 U2OS H3K27ac C207 treat…
- GSM8404631 U2OS IgG no treatment Rep1 U2OS IgG no treatment
- GSM8404632 U2OS IgG no treatment Rep2 U2OS IgG no treatment
- GSM8404633 U2OS IgG no treatment Rep3 U2OS IgG no treatment
- GSM8404634 U2OS IgG C207 treatment Rep1 U2OS IgG C207 treatment
- GSM8404635 U2OS IgG C207 treatment Rep2 U2OS IgG C207 treatment
- GSM8404636 U2OS IgG C207 treatment Rep3a
- GSM8833011 U2OS cells, no infection, DMSO, biological replicate 1 U2OS cells, no infectio…
- GSM8833012 U2OS cells, no infection, DMSO, biological replicate 2 U2OS cells, no infectio…
- GSM8833013 U2OS cells, no infection, DMSO, biological replicate 3 U2OS cells, no infectio…
- GSM8833014 U2OS cells, no infection, DMSO, biological replicate 4 U2OS cells, no infectio…
- GSM8833015 U2OS cells, no infection, 300 nM C207, biological replicate 1 U2OS cells, no infectio…
- GSM8833016 U2OS cells, no infection, 300 nM C207, biological replicate 2 U2OS cells, no infectio…
- GSM8833017 U2OS cells, no infection, 300 nM C207, biological replicate 3 U2OS cells, no infectio…
- GSM8833018 U2OS cells, no infection, 300 nM C207, biological replicate 4 U2OS cells, no infectio…
- GSM8833019 U2OS cells, 10k vg/cell AAV2 Jet-FKBP*, 300 nM C207, biological replicate 1 U2OS cells, 10k vg/cell…
- GSM8833020 U2OS cells, 10k vg/cell AAV2 Jet-FKBP*, 300 nM C207, biological replicate 2 U2OS cells, 10k vg/cell…
+ 6 more — browse all 46 samples with per-sample file links →
- GSE271090 Centralized control of dynamic gene regulatory circuits governs human T cell rest and activation 443 samples shares activation, dynamic
- GSE277721 Genome-wide in vivo dynamics of cohesin-mediated loop extrusion and its role in transcription activation 176 samples shares activation, dynamic
- GSE298022 JNK activation dynamics drive distinct gene expression patterns over time mediated by mRNA stability 45 samples shares activation, dynamic
- GSE270902 Twist1-induced suppression of oncogene-induced senescence in non-small cell lung cancer requires the transactivation domain of Twist1 12 samples shares activation, small
- GSE230342 Chromatin conformation dynamics during CD4+ Tcell activation implicates autoimmune disease associated genes and regulatory elements (HiC) 6 samples shares activation, dynamic
- GSE290367 Single-cell multiomic integration identifies widespread, cell-type resolved fetal reactivation in the diseased human heart 90 samples shares activation
- GSE324815 Intratumoral CD40 agonist sotigalimab in combination with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: Results of a phase 1/2 study 24 samples shares activation
- GSE274680 Inflammation and lymphocyte activation during longitudinal progression to rheumatoid arthritis in at-risk individuals 243 samples shares activation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.